Most cancer patients believe surgery will be curative

Most cancer patients believe surgery will be curative

(HealthDay)—Most patients undergoing surgery for lung or colorectal cancer believe that the surgery is likely to be curative, according to a study published in the Oct. 15 issue of Cancer.

Yuhree Kim, M.D., from Johns Hopkins University in Baltimore, and colleagues characterized the prevalence of the expectation that of lung or colorectal cancer might be curative among 3,954 patients who underwent cancer-directed surgery for lung (30.3 percent) or colorectal (69.7 percent) cancer. Patients were identified from a population-based and health system-based survey of participants from multiple U.S. regions.

The researchers found that 80.0 percent of patients with lung cancer and 89.7 percent of those with colorectal cancer responded that surgery would cure their cancer. Even among patients with stage IV lung and , 57.4 and 79.8 percent, respectively, believed surgery was likely to be curative. The odds ratio (OR) of the perception of curative intent was higher among patients with colorectal versus (OR, 2.27). Higher odds of perceiving surgery would be curative were also seen among patients who reported optimal physician communication scores (score of 80 to 100 versus reference score of 0 to 80; OR, 1.40) and those reporting a shared role in decision-making with their physician (OR, 1.16) or family (OR, 1.17). Patients who were less likely to believe that would cure their cancer were unmarried female with an advanced tumor stage and a higher number of comorbidities.

"Greater focus on patient-physician engagement, communication, and barriers to discussing goals of care with who are diagnosed with cancer is needed," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Cancer

Copyright © 2015 HealthDay. All rights reserved.

Citation: Most cancer patients believe surgery will be curative (2015, October 8) retrieved 10 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Second primaries for over 25 percent with metastatic prostate cancer


Feedback to editors